咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Effectiveness of non-pyrimetha... 收藏

Effectiveness of non-pyrimethamine-based regimens for toxoplasma encephalitis:A systematic and meta-synthesis study

作     者:David Susanto Arthur H.P.Mawuntu Finny Warouw Windy M.V.Wariki David Susanto;Arthur H.P.Mawuntu;Finny Warouw;Windy M.V.Wariki

作者机构:Neurology DepartmentFaculty of MedicineSam Ratulangi University/R.D.Kandou HospitalManadoIndonesia Department of Community MedicineFaculty of MedicineSam Ratulangi UniversityManadoIndonesia 

出 版 物:《Asian Pacific Journal of Tropical Medicine》 (亚太热带医药杂志(英文版))

年 卷 期:2022年第15卷第3期

页      面:106-113页

核心收录:

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100204[医学-神经病学] 10[医学] 

主  题:Toxoplasma encephalitis Alternative treatment Without pyrimethamine Systematic review Meta-synthesis 

摘      要:Objective:To examine the differences in effectiveness and side effects between pyrimethamine-based and non-pyrimethamine-based regimens for toxoplasma encephalitis since the availability of pyrimethamine in Indonesia is currently limited due to its withdrawal from the ***:A systematic review and meta-synthesis study that was carried out by following a protocol guided by the Preffered Reporting Items for Systematic Review and Meta-analysis(PRISMA).Effectiveness measures included clinical improvement,mortality,and radiological *** evaluated selected articles narratively because of the limitations of *** risk of bias in RCTs was assessed using the Cochrane Risk of Bias tool for RCT(ROB 2.0)and cohort studies were assessed using the Risk of Bias In Non-Randomized Studies of Interventions(ROBINS-1)*** quality was assessed using the GradePro ***:We included two retrospective cohort studies and one *** outcome assessment in these three studies did not show significant difference in effectiveness between pyrimethamine-based and non-pyrimethamine-based regimens for toxoplasma encephalitis ***,drug side effects were consistently higher in the pyrimethamine-based ***:This study has a high risk of *** quality of the research also has a low recommendation ***,the results may be considered for application if a standard regimen is not available.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分